Tag: Brazil Health Regulator
RIO DE JANEIRO, BRAZIL - The indiscriminate use of paracetamol for pain and fever relief after Covid-19 vaccination can lead to serious adverse events, including drug hepatitis and death, Brazil's health regulatory agcency ANVISA has indicated.
According to the agency,...
RIO DE JANEIRO, BRAZIL - On Thursday, May 13, Fiocruz's Institute of Technology in Pharmaceuticals was granted final approval by the Brazilian Health Regulatory Agency (ANVISA) to produce cannabidiol - a medicinal derivative of marijuana.
The institution is the third...
RIO DE JANEIRO, BRAZIL - Facing the risk of collapse in the health system, the National Health Regulatory Agency (ANVISA) relaxed the rules about oxygen cylinders.
The four measures announced by the agency last Friday night aim to avoid the...
RIO DE JANEIRO, BRAZIL - Remdesivir, the first drug approved in Brazil with an indication in the package insert for the treatment of Covid-19, can reduce the hospitalization time for patients with the disease, according to ANVISA, the National...
RIO DE JANEIRO, BRAZIL - Brazil’s health regulator is seeking further data on Russia’s Sputnik V coronavirus vaccine before considering its approval for emergency use.
Documents supporting drugmaker União Química’s application for emergency use of the vaccine have been returned...
RIO DE JANEIRO, BRAZIL - Brazilian health authority Anvisa said on Saturday, January 9th, that the application from São Paulo-based medical center Butantan for emergency use of a COVID-19 vaccine developed by China’s Sinovac Biotech lacks some relevant information...
RIO DE JANEIRO, BRAZIL - Brazil’s health regulator Anvisa decided on Thursday to allow temporary emergency use authorizations for COVID-19 vaccines and set rules for companies to apply for the option that did not exist in the country.
The decision...
